Health News

Durvalumab immunotherapy with standard chemotherapy improved survival in malignant pleural mesothelioma

The PrE0505 phase 2 clinical trial results are published in the November 8 issue of Nature Medicine. The study evaluated the addition of durvalumab immunotherapy to standard chemotherapy in patients with previously untreated, inoperable malignant pleural mesothelioma (MPM), a cancer of the tissues that line the lungs. The trial met its primary endpoint with a median […]

Health News

Mixed results seen with eHealth program for cancer survivors

(HealthDay)—Cancer survivors appear to experience variable benefit from an eHealth self-management program designed to increase self-efficacy for managing cancer-related issues, according to a study published online Oct. 20 in Cancer. Corinne R. Leach, Ph.D., M.P.H., from the American Cancer Society in Atlanta, and colleagues conducted a randomized controlled trial to examine the efficacy of and […]